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Objective: To investigate the relationships between the apparent diffusion coefficients (ADCs) on diffusion-weighted 
imaging (DWI) and the speed of contrast-enhancement in hepatic hemangiomas.
Materials and Methods: Sixty-nine hepatic hemangiomas (≥ 1 cm) were evaluated with DWI, by using multiple b values (b 
= 50, 400, 800 s/mm2), followed by a gadolinium-enhanced dynamic MRI. The lesions were classified into three groups, 
according to the speed of contrast-enhancement on the portal phase. ADCs were measured on the ADC map automatically, 
and were calculated by using the two different b values (mADC50-400 with b values = 50 and 400; mADC400-800 with b values = 
400 and 800 s/mm2).
Results: The mean ADCs (x 10-3 mm2/s) were significantly higher in the rapid group (1.9 ± 0.44) than in the intermediate 
(1.7 ± 0.35, p = 0.046) or the slow groups (1.4 ± 0.34, p = 0.002). There were significant differences between the rapid 
and the slow groups in mADC50-400 (2.12 vs. 1.48; p = 0.008) and mADC400-800 (1.68 vs. 1.22, p = 0.010), and between the 
rapid and the intermediate groups in mADC50-400 (2.12 vs. 1.79, p = 0.049). Comparing mADC50-400 with mADC400-800, there was 
a significant difference only in the rapid group (p = 0.001).
Conclusion: Higher ADCs of rapidly-enhancing hemangiomas may be related to richer intralesional vascular perfusion. Also, 
the restricted diffusion may be attributed to the difference of structural characteristics of hemangioma.
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INTRODUCTION
Hemangiomas are the most common benign tumors of 
the liver, and their characteristic imaging features have 
been well documented and widely accepted as a diagnostic 
on dynamic contrast enhanced computed tomography (CT) 
and magnetic resonance imaging (MRI) (1). However, some 
hepatic hemangiomas, with atypical imaging features, 
such as extremely slow or rapid contrast material filling-
in during the dynamic imaging in addition to the internal 
hemorrhagic or sclerotic components, remain difficult to 
differentiate from other hepatic lesions (2).
The diffusion-weighted MR imaging (DWI) produces 
an image contrast depending on the movement of the 
extracellular water, and offers a means of quantifying the 
diffusion effects via the measurement of the apparent 
diffusion coefficient (ADC). Recently, the application of 
DWI in the upper abdomen has become practical and 
recommended as an adjunct to MRI of the liver that can 
be performed within an acceptably short amount of time. 
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Several recent reports have suggested that ADCs on DWI are 
useful for the characterization of focal hepatic lesions (3-8). 
Although there are large discrepancies in the reported 
ADC values in the abdomen, caused by variability in MR 
machines and applied MR parameters at each institute, 
most studies show lower ADC values in the malignant 
lesions than in the benign lesions, including cysts (9). 
Hepatic hemangiomas have shown various degrees of 
signal intensities and ADCs in several studies that have 
evaluated cystic and solid tumors (3, 5-9). In practice, 
some hepatic hemangiomas show relatively low ADCs on 
DWI, which significantly overlap with those of solid tumors, 
such as hepatocellular carcinomas or liver metastases 
(9). In a recent study by Goshima et al. (10), using DWI 
with b factors of 0 and 500 s/mm2, which consisted of 
only one trial to correlate DWI features with the pattern 
of intralesional blood flow in hepatic hemangiomas, early 
enhancing lesions showed higher ADCs than did the slowly 
enhancing lesions. In the meanwhile, by using the multiple 
b factors, we hypothesized that we could verify their results 
and separate the ADC changes from other factors besides 
the perfusion difference.
The purpose of our study was two-fold. First, we 
investigated the relationships between the speed of 
contrast enhancement during the dynamic imaging and the 
ADC values on DWI using multiple b factors to enhance the 
accuracy of the automatically calculated values on the ADC 
maps. Second, for cases in which the ADC varied with the 
speed of enhancement of the hemangioma, we manually 
calculated ADCs using several different combinations of two 
b factors to investigate the cause of the ADC differences. 
MATERIALS AND METHODS
Patient Populations
The institutional review board at our hospital approved 
the retrospective study protocol and waived informed 
consent for the individual patients. Among the 780 
consecutive patients examined, via a hepatic MRI with 
dynamic imaging and DWI during a two-year period 
(from March 2007 to March 2009), 47 patients (20 men, 
27 women; age range 26-79 years; mean age, 53 years) 
with 69 hepatic hemangiomas (≥ 1 cm) were included. 
Regardless of the number of lesions in each patient, 
all of the hepatic hemangiomas were enrolled by the 
following criteria. Hepatic hemangiomas were diagnosed 
using the combination of pre-established typical imaging 
features, including a strong T2-weighted hyperintensity, in 
addition to the early peripheral globular enhancement and 
centripetal enhancement on a dynamic MRI and CT. For T2-
weighted hyperintense lesions on dynamic imaging, which 
showed an early homogeneous and sustained enhancement 
similar to the intrahepatic vasculature, long-term (12 month 
or longer) follow-up imaging studies were added to confirm 
that the lesions were benign (1). Lesions with diameters of 
1.0 cm or greater were enrolled because the measurements 
of smaller lesions would not be sufficiently reliable, due 
to the partial volume averaging effect, which can result in 
underestimation in the quantitative measurement of ADC 
values. 
MRI Techniques
Magnetic resonance imaging was performed using a 1.5-
T unit (Magnetom Avanto; Siemens Medical Solutions, 
Erlangen, Germany), equipped with high-performance 
gradients (maximum amplitude 45 mT/m) and a six-element 
phased-array surface coil. After determination of the 
optimal timing for the arterial phase imaging, using the 
timing bolus technique, dynamic contrast-enhanced imaging 
was obtained after the administration of a bolus injection 
of the gadopentetate dimeglumine (0.1 mmol/kg of 
Magnevist; Bayer Schering Pharma, Leverkusen, Germany), 
at a rate of 2 mL/sec. We used a 3D gradient echo sequence 
(VIBE; Siemens, Erlangen, Germany) with ultrafast image 
reconstruction, using the parallel imaging algorithms 
(GeneRalized Autocalibrating Partially Parallel Acquisitions 
[GRAPPA] factor = 2) in the axial plane (Repetition Time 
[TR] = 4.4 ms, Echo Time [TE] = 2.1 ms, flip angle = 10°, 
matrix = 448 x 224, field of view [FOV] = 271 x 379 mm, 
slice thickness = 5 mm, slice spacing = 2.5 mm, slices = 
72) during a 20 s breath-holding period. A dynamic series 
consisted of one precontrast series, followed by three 
successive postcontrast series, including an early arterial, 
late arterial, and portal phase imaging, at 34 s intervals (20 
s for image acquisition with breath-holding and 14 s for re-
breathing), at the start of each phase imaging followed by 
a 5-minute delayed phase imaging. 
Diffusion-weighted MR imaging was performed before 
the dynamic imaging, using a single-shot spin-echo echo 
planar imaging (EPI) sequence with the b factors of 50, 
400, and 800 s/mm2 along the three orthogonal directions. 
The sequence was obtained within a single breath-holding 
period for the upper half of the liver and another single 
breath-holding period for the lower half of the liver. Other 
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technical parameters included: TR = 1000 ms, TE = 69 
ms, matrix = 128 x 192, FOV = 30 to 40 cm adapted to 
individual body size, nine slices for each b factor for each 
half of the liver (total 18 slices for entire liver), thickness 
= 6 mm, interslice gap = 30%, average = 2, bandwidth = 
1735 Hz/pixel, and acquisition time = 22 s for each breath-
holding period. The parallel imaging algorithms (GRAPPA), 
with an acceleration factor of 2, were added to reduce the 
acquisition time. Spectral fat saturation was employed 
systematically to suppress the chemical-shift artifacts. 
ADC maps regarding isotropic images were automatically 
acquired and all mean ADCs of the lesions were measured 
on those maps. To improve the signal-to-noise ratio and 
for patient convenience, DWI, under free-breathing, was 
alternatively performed. Imaging parameters, different from 
the above breath-holding sequence, were as follows: TR = 
3900 ms, TE = 75 ms, matrix = 156 x 192, slices = 78 (26 
slices for each b factor), thickness = 6 mm with interslice 
gap = 20%, and the average = 4. Acquisition time for 
the entire liver using the three different b factors was 80 
seconds, and all other parameters were the same as those in 
the breath-holding technique. 
Data Analysis
Three radiologists classified each lesion into three groups, 
according to the speed of intratumoral enhancement 
determined by consensus. Classification was determined 
using the visually-estimated proportion of contrast 
enhancement in the entire tumor volume on portal phase 
images (group 1, > 75% [rapid, n = 26]; group 2, 25-75% 
[intermediate, n = 28]; group 3, < 25% [slow, n = 15]). 
Automatically, the calculated mean ADCs using all three b 
factors were obtained in operator-defined regions of interest 
(ROI) on the ADC maps (Figs. 1, 2). Additionally, through 
ROI drawing directly on the diffusion images with three 
different b factors (Figs. 1, 2), two ADCs were manually 
calculated with two different b factors (e.g., mADC50-400 with 
b = 50 and 400 s/mm2; mADC400-800 with b = 400 and 800 s/
mm2) using the following equation: mADC = (ln[SI1/SI2])/
(b2-b1), where b1 is the smaller b factor, b2 is the larger b 
Fig. 1. Fifty six-year-old male patient with rapidly enhancing hepatic hemangioma (group 1) (on S8, 20 mm in diameter). 
A. In portal phase of dynamic MRI, greater than 75% contrast filling is seen, categorized as group 1. B. On ADC map, ADC value is automatically 
measured as 2.195 x 10-3 mm2/s. C-E. Based on signal intensities of DWI images with multiple b values (b = 50, 400, 800 s/mm2, respectively), 
mADC50-400 (2.704 x 10-3 mm2/s) is higher than mADC400-800 (2.169 x 10-3 mm2/s). ADC = apparent diffusion coefficient, DWI = diffusion weighted 
imaging
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factor, and SI1 and SI2 represent the corresponding signal  
intensities, which were obtained in the regions of interest 
on each b factor image. All of the measurement processes 
were performed by each of three independent radiologists, 
who already determined the speed of enhancement, during 
the dynamic imaging, but temporarily blinded for the pre-
determined classification of each lesion, and all three 
measured values were averaged for further analyses.
Statistical Analysis
One-way analysis of variance (ANOVA) was used to 
compare the size differences among the different groups 
of hemangiomas. Pearson’s correlation test was used to 
evaluate the relationship between the lesion size and ADC. 
Student’s t test was used to compare the automatically 
calculated ADCs and mADCs to define a multiple paired 
group-to-group differences. The differences between mADCs 
for each group were also evaluated. All statistical analyses 
were performed using a software package (SPSS 13.0. for 
Windows; SPSS, Chicago, IL, USA), and differences were 
considered as significant when the p value was less than 0.05.
RESULTS
Regarding the mean lesion size, group 1 (n = 26, 1.64 ± 
0.80 cm) was similar to that of group 3 (n = 15, 1.53 ± 0.66 
cm), and smaller than group 2 (n = 28, 2.44 ± 1.87 cm); 
however, these differences were not significant (p = 0.064). 
There was no significant correlation between the ADCs 
measured on the automatically calculated ADC maps and the 
sizes of the lesions (r = 0.148, p = 0.226). The mean ADC 
(x 10-3 mm2/s) measured on the ADC maps was significantly 
higher in group 1 (1.91 ± 0.44) than were the mean ADCs of 
group 3 (1.48 ± 0.34) (p = 0.002) and group 2 (1.70 ± 0.35) 
(p = 0.046) (Figs. 1-3) (Table 1). There was no significant 
difference in the mean ADCs between groups 2 and 3 (p = 
0.052). 
Among the manually calculated ADCs, there were 
Fig. 2. Fifty four-year-old male patient with slowly enhancing hepatic hemangioma (group 3) (on S7, 21 mm in diameter).
A. In portal phase of dynamic MRI, less than 25% contrast filling is seen, categorized as group 3. B. On ADC map, ADC value is automatically 
measured as 1.498 x 10-3 mm2/s. C-E. Based on signal intensities of DWI images with multiple b values (b = 50, 400, 800 s/mm2, respectively), 
mADC50-400 (1.134 x 10-3 mm2/s) is not higher than mADC400-800 (1.636 x 10-3 mm2/s). ADC = apparent diffusion coefficient, DWI = diffusion 
weighted imaging
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significant differences between group 1 and 3 (mADC50-
400, 2.12 vs. 1.48, p = 0.008; mADC400-800, 1.68 vs. 1.22, 
p = 0.010) (Table 1). Between group 1 and 2, there was 
a significant difference in mADC50-400 (2.12 vs. 1.79, p = 
0.049), but not in mADC400-800 (1.68 vs. 1.52, p = 0.222). 
There were no significant differences with regard to mADCs, 
between groups 2 and 3 (mADC50-400, 1.79 vs. 1.48, p = 
0.187; mADC400-800, 1.52 vs. 1.22, p = 0.085). We observed a 
significant difference between mADC50-400 and mADC400-800 in 
group 1 (2.12 vs. 1.68; p = 0.001), but this difference was 
not seen in the other groups (group 2, 1.79 vs. 1.52, p = 
0.096; group 3, 1.48 vs. 1.22, p = 0.433) (Fig. 4).
DISCUSSION
Apparent diffusion coefficients on DWI permit 
quantification of the combined effects of the 
microcirculation of blood (perfusion) and molecular 
Brownian motion of water (diffusion) within the tissue 
(8, 9). In the majority of the malignant lesions, increased 
cellularity and distortion of the extracellular space lead to a 
restriction of diffusion, thereby decreasing the ADC. Cystic 
lesions, including the common benign cysts and liquefied 
Fig. 4. Logarithmic plot of signal intensity against b value 
in each group (group 1, rapid; group 2, intermediate; group 
3, slow). Slope of plot is represented by mADC50-400 (50-400 s/mm2) 
and mADC400-800 (400-800 s/mm2). mADC50-400 is higher, represented 
as stiffer slope, than mADC400-800 only in group 1 and results in slight 
bending b = 400 mm2/s which was not observed in other groups of 
hemangiomas showing straighter slope regardless of sizes of b factors.
ADC = apparent diffusion coefficient.
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Fig. 3. Box-plots of apparent diffusion coefficients (ADCs) 
measured in hepatic hemangiomas showing different speed 
(rapid, intermediate, or slow) of contrast enhancement during 
dynamic imaging. Decimal numbers on y-axis are mean ADCs (x 10-3 
mm2/s) measured using region-of-interest on automatically-calculated 
ADC maps. Ranges of ADC values are overlapping each other in spite of 
significant difference of mean values between rapid and other lesions.
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Table 1. Comparison of Mean Automatically Calculated ADCs (x 10-3 mm2/s) and Mean Manually Calculated ADCs of Hemangiomas 
between Groups Classified according to Speed of Contrast Enhancement
Speed of Contrast 
Enhancement
Automatically Calculated
ADCs* ± SD
(x 10-3 mm2/s)
Manually Calculated ADCs (x 10-3 mm2/s)
mADC50-400* mADC400-800†
P in
mADC50-400 vs. mADC400-800
Group 1 (n = 26) 1.91 ± 0.44 2.12 1.68 0.001
Group 2 (n = 28) 1.70 ± 0.35 1.79 1.52 0.096
Group 3 (n = 15) 1.48 ± 0.34 1.48 1.22 0.433
P in
Group 1 vs. 2 0.046 0.049 0.222
Group 1 vs. 3 0.002 0.008 0.010
Group 2 vs. 3 0.052 0.187 0.085
Note.— *ADCs measured on automatically provided ADC maps using multiple b factors, †Manually calculated ADCs with linear regression 
method using lesional signal intensities (mADCs) on each DWI with two different b factors. ADC = apparent diffusion coefficient, DWI = 
diffusion weighted imaging, SD = standand deviation
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necrosis in solid lesions, contain free moving protons that 
allow for free diffusion and result in high ADCs. Meanwhile, 
the hepatic hemangiomas consist of cavernous vascular 
spaces that allow for free diffusion of water molecules and 
intervening interstitial septa that restrict molecular motion. 
The ADCs of hemangiomas demonstrated an inhomogeneous 
appearance in some cases, higher values overlapped with 
those of some cysts, and the lower values overlapped with 
those of some metastases or, rarely, other solid tumors, 
making it difficult to distinguish hemangiomas from other 
hepatic tumors on DWI (3, 5-7, 11).
In the early period of DWI use in liver imaging, it had 
been already found that ADCs depend on the sizes of the 
b factors (6, 11-14); when a large b factor is used, ADCs 
approximate the true value of the tissue, whereas, a small b 
factor results in the influence of intravoxel perfusion on the 
ADCs, which are then usually overestimated. Considering 
the variability, in contrast to the enhancement speed on 
dynamic CT or MRI, which reflect the variability of blood 
flow in the cavernous spaces of hepatic hemangiomas, we 
tried to identify a relationship between the enhancement 
speed and ADCs of hepatic hemangiomas via quantification 
of the signal intensity attenuation, during DWI, using 
multiple small and large b factors. We presumed that a 
manual calculation of the ADCs with two smaller b factors 
(mADC50-400) would be more affected by an intralesional 
blood flow, and might be different from the ADCs calculated 
using the two larger b factors (mADC400-800), which are 
relatively unaffected by the perfusion effect. In the 
present study, the mean ADCs, measured on the ADC maps 
in the different groups of hepatic hemangiomas, were 
well correlated with the speed of contrast enhancement, 
similar to the results of a previous study by Goshima et al., 
who used a single intermediate b factor (500 s/mm2) (5). 
Manually calculated mADCs demonstrated that the rapidly 
enhancing hemangiomas have significantly higher ADCs, 
when they are calculated with the smaller b factors (50 
and 400 s/mm2), compared with the ADCs calculated with 
the larger b factors (400 and 800 s/mm2); this effect was 
not observed in the slowly enhancing hemangiomas (Fig. 
4). Our results suggest that only the rapidly enhancing 
hemangiomas are grossly influenced by the intralesional 
vascular perfusion, while the others are hardly affected by 
the sizes of the b factors for their ADCs.
When we compared mADCs with the use of the same b 
factors, among the three groups, it was interesting that 
there were significant differences not only for mADC50-400, 
but also for mADC400-800 between the rapidly enhancing and 
the slowly enhancing groups. On a logarithmic plot of the 
signal intensity versus the various b factors (Fig. 4), rapidly 
enhancing hemangiomas showed a stiffer slope of the signal 
attenuation representing a higher mADC than did the other, 
more slowly enhancing hemangiomas, even at larger b 
factors, which are relatively free from the effects of vascular 
perfusion. Depending on this observation, besides the speed 
of the blood flow in the cavernous spaces, there should be 
other factors to determine ADC of hepatic hemangiomas, 
showing a different speed of contrast enhancement. 
In a previous study dealing with the correlations between 
the dynamic imaging and pathology of hepatic cavernous 
hemangiomas, Yamashita et al. (15) suggested that the 
lesions with wider cavernous spaces are more slowly 
enhancing because of the longer duration for complete 
intralesional contrast material filling-in. Additionally, 
intralesional fluid-fluid level, suggesting a separation of 
blood cells and serous fluid by the stagnant blood flow 
in the wide cavernous spaces, has been observed in some 
extreme cases of slowly enhancing hemangiomas (16-19). 
In such situation, we could suggest that this effect may 
contribute to the lower mADC400-800 values of the slowly 
enhancing hemangiomas from the restricted water diffusion 
at the area of cellular aggregation in the wide cavernous 
spaces. Considering a different opinion by Yu et al. (20), 
which opposes the suggestions of Yamashita et al., however, 
there could be a different explanation for the restricted 
diffusion for the slowly enhancing hemangiomas; the 
hemangiomas with narrower cavernous spaces would have 
relatively more abundant and thick irregular intervening 
septa, which could disturb molecular diffusion, resulting 
in lower ADCs in addition to higher resistance to vascular 
inflow to the cavernous space. Using this line of thought, 
wider cavernous spaces would allow more free molecular 
motion, as well as richer perfusion, due to the effects of 
low resistance of the thinner septa on the arterial inflow, 
resulting in higher ADCs.
Our study has several limitations. First, due to the lack of 
pathologic specimen, we could not correlate the DWI feature 
with the histological characteristics. Besides the structural 
differences of the cavernous space, some degenerative 
processes, like the internal hemorrhage, calcification or 
sclerosis, could affect the ADC of hepatic hemangiomas. 
Most of the rapidly and slowly enhancing hemangiomas 
(group 1 and 3 cases) of our study were smaller than 2 cm, 
showing a homogeneous hyperintensity on T2-weighted 
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images throughout the lesion, and there was no grossly 
defined isolated unenhancing component until the 5-minute 
delayed phase post-contrast images. Even though there 
was no gross suggestive finding of internal degeneration, 
however, the presence of microscopic hemorrhagic foci 
or sclerotic components, lowering the ADC, could not be 
excluded without histological information. Second, there 
were some inevitable technical limitations, despite the 
use of updated DWI technology to improve image quality 
and lesion conspicuity. Even though we excluded the sub-
centimeter lesions, there could have been some section 
misalignment or partial volume artifact, which leads to 
an inaccurate measurement of the ADC. When the lesion 
is located on the left lobe of the liver, cardiac motion can 
result in increases in the ADC, due to signal loss on images 
using the larger b factors. In the present study, at least 10 
lesions were located in the left lobe of the liver, and among 
the rapid enhancing hemangiomas, only 7% were the left 
lobe lesions; therefore, we feel that the cardiac motion 
effect had a minor, if any, influence on our results. Third, 
we used two different DWI data acquisition techniques and 
there could be variability in the ADC measurement between 
the two techniques. In a previous study, however, there was 
no significant difference of the measured ADCs between the 
breath-holding and free-breathing techniques, while the 
respiratory-triggered technique, which we did not use in the 
present study, could show higher ADC values by the pseudo-
anisotrophy phenomenon (21, 22). Last, we did not perform 
DWI with b = 0, and the early component of signal loss with 
b factors under 50 mm2/s, which is considerably affected 
by the vascular perfusion effect (11), was not reflected in 
our results, in this retrospective study. If we had another 
mADCs data using b = 0 and b = 50 mm2/s, we might obtain 
higher mADCs, which emphasizes the perfusion effect for 
rapidly enhancing hemangiomas. We would like to see 
further studies that includes DWI data, using b = 0 mm2/s 
or prospective study with the use of multiple small and 
large b factors for biexponential fitting to generate the 
intravoxel incoherent motion parameters (11) to reinforce 
the results of our study. 
In conclusion, as compared with slowly enhancing 
hemangiomas, rapidly enhancing hepatic hemangiomas 
have higher ADCs that are considerably dependent on their 
rapid attenuation of signal intensities on DWI, using the 
smaller b factors, suggesting that the higher speed of blood 
flow in the cavernous space may significantly contribute 
to the tendency toward higher ADCs. On the other hand, 
the differences of manually calculated ADCs, using the 
larger b factors, which are hardly affected by vascular 
perfusion, suggest that the differences in molecular 
diffusion could be rather related to the differences of 
the intralesional architecture with or without internal 
degenerative processes, among the different speed groups 
of hemangiomas. Regarding the practical implications, such 
DWI features of hepatic hemangiomas could be helpful 
in the differential diagnosis of focal hepatic lesions. For 
example, hypervascular solid tumors can be distinguished by 
their low ADCs, from the rapidly enhancing hemangiomas, 
showing high ADCs; meanwhile, centrally necrotic, cystic 
or mucinous metastatic tumors would show high ADCs 
and can be distinguished from the very slowly enhancing 
hemangiomas with low ADCs. For verification of the relevant 
issues, further studies should be followed.
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